The metalloproteinase inhibitor batimastat (BB-94) causes cell cycle phase perturbations in ovarian cancer cells.
Erba
E
E
Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. erba@irfmn.mnegri.it
Ronzoni
S
S
Bassano
L
L
Giavazzi
R
R
D'Incalci
M
M
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000378:metabolism; D002453:Cell Cycle / Q000187:drug effects; D005260:Female; D006801:Humans; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D010051:Ovarian Neoplasms / Q000473:pathology*; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology*; D013876:Thiophenes / Q000494:pharmacology*
D000970:Antineoplastic Agents; D011480:Protease Inhibitors; D013876:Thiophenes; D010649:Phenylalanine; C080985:batimastat; D008666:Metalloendopeptidases; D001973:Bromodeoxyuridine